Stratification of cancer-therapy related cardiac dysfunction: a validated prediction tool to identify low risk patients
Cancer therapy-related cardiac dysfunction (CTRCD) is a major concern in patients undergoing anticancer therapy. Risk assessment tools aid clinical practice in patient-risk stratification, guiding follow-up and management. The aim of this study is to develop and externally validate a clinical prediction to...